NATHAN CARBERRY MD
Prescription History 1083147839
Psychiatry & Neurology - Neuromuscular Medicine in Miami, FL


Quality Rating: 81.31 out of 100 score

NPI Status: Active since April 08, 2017

Contact Information

1120 NW 14TH ST
MIAMI, FL
ZIP 33136
Phone: (305) 243-2000

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for NATHAN CARBERRY MD, an active Neuromuscular Medicine specialist practicing in Miami, FL. Our medical registry currently tracks 14 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 455 documented patient claims. Among these therapy options, the most frequently utilized medication is Relyvrio, which accounts for 82 claims alone.


Atropine Sulfate

Generic Formulation: Atropine SulfateSpecialty: Neurology
Provider Metrics Summary
Total Claims 23
30-Day Fills 32.9
Days Supply 977
FL State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills39.9
Peer Average Days Supply1,014
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,276.15 across this reporting matrix range.

Provider Avg Cost Per Claim

$98.96

State Avg Cost Per Claim

$46.36

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An alkaloid, originally from Atropa belladonna, but found in other plants, mainly SOLANACEAE. Hyoscyamine is the 3(S)-endo isomer of atropine.

Therapeutic Applications

This medication is used before eye examinations (such as refraction) and to treat certain eye conditions (such as uveitis). It belongs to a class of drugs known as anticholinergics. Atropine works by widening (dilating) the pupil of the eye.

Baclofen

Generic Formulation: BaclofenSpecialty: Neurology
Provider Metrics Summary
Total Claims 22
30-Day Fills 42.0
Days Supply 1,260
FL State Average Benchmarks
Peer Average Claims49.0
Peer Average 30-Day Fills67.6
Peer Average Days Supply1,850
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 55.1% less volume than the regional standard for practitioners inside FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $483.02 across this reporting matrix range.

Provider Avg Cost Per Claim

$21.96

State Avg Cost Per Claim

$24.56

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A GAMMA-AMINOBUTYRIC ACID derivative that is a specific agonist of GABA-B RECEPTORS. It is used in the treatment of MUSCLE SPASTICITY, especially that due to SPINAL CORD INJURIES. Its therapeutic effects result from actions at spinal and supraspinal sites, generally the reduction of excitatory transmission.

Therapeutic Applications

Baclofen is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury/disease). It works by helping to relax the muscles.

Duloxetine Hcl

Generic Formulation: Duloxetine HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 15
30-Day Fills 27.4
Days Supply 820
FL State Average Benchmarks
Peer Average Claims51.0
Peer Average 30-Day Fills99.4
Peer Average Days Supply2,948
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 70.6% less volume than the regional standard for practitioners inside FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $366.84 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.46

State Avg Cost Per Claim

$45.79

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A thiophene derivative and selective NEUROTRANSMITTER UPTAKE INHIBITOR for SEROTONIN and NORADRENALINE (SNRI). It is an ANTIDEPRESSIVE AGENT and ANXIOLYTIC, and is also used for the treatment of pain in patients with DIABETES MELLITUS and FIBROMYALGIA.

Therapeutic Applications

Duloxetine is used to treat depression and anxiety. In addition, duloxetine is used to help relieve nerve pain (peripheral neuropathy) in people with diabetes or ongoing pain due to medical conditions such as arthritis, chronic back pain, or fibromyalgia (a condition that causes widespread pain). Duloxetine may improve your mood, sleep, appetite, and energy level, and decrease nervousness. It can also decrease pain due to certain medical conditions. Duloxetine is known as a serotonin-norepinephrine reuptake inhibitor (SNRI). This medication works by helping to restore the balance of certain natural substances (serotonin and norepinephrine) in the brain.

Gabapentin

Generic Formulation: GabapentinSpecialty: Neurology
Provider Metrics Summary
Total Claims 62
30-Day Fills 99.7
Days Supply 2,821
FL State Average Benchmarks
Peer Average Claims103.0
Peer Average 30-Day Fills177.9
Peer Average Days Supply5,249
Conservative Utilization

This provider writes prescriptions for this formulation 39.8% less frequently than the standard regional baseline metric for practitioners inside FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,864.87 across this reporting matrix range.

Provider Avg Cost Per Claim

$30.08

State Avg Cost Per Claim

$19.25

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.

Therapeutic Applications

Gabapentin is used with other medications to prevent and control seizures. It is also used to relieve nerve pain following shingles (a painful rash due to herpes zoster infection) in adults. Gabapentin is known as an anticonvulsant or antiepileptic drug.

Gamunex-C

Generic Formulation: Immune Globul G/Gly/Iga Avg 46Specialty: Neurology
Provider Metrics Summary
Total Claims 64
30-Day Fills 64.0
Days Supply 1,344
FL State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills31.7
Peer Average Days Supply805
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 106.5% higher than the standard regional baseline profile for FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $359,491.31 across this reporting matrix range.

Provider Avg Cost Per Claim

$5,617.05

State Avg Cost Per Claim

$8,997.69

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used in people with a certain type of weakened immune system (primary immune deficiency) to strengthen it and to lower the risk of infection. This medication is made from human blood that has a high level of antibodies which help fight infections. This product is also used to increase the number of certain blood cells (platelets) in people with a certain blood disorder (idiopathic thrombocytopenic purpura-ITP). Platelets are needed to stop bleeding and to form normal blood clots. In addition, this medication is used to treat a certain nerve disorder (chronic inflammatory demyelinating polyneuropathy-CIDP). This disorder causes weakness and numbness/tingling/pain in the arms and legs. This medication helps to improve these symptoms and prevents relapse.

Glycopyrrolate

Generic Formulation: GlycopyrrolateSpecialty: Neurology
Provider Metrics Summary
Total Claims 27
30-Day Fills 33.3
Days Supply 995
FL State Average Benchmarks
Peer Average Claims20.0
Peer Average 30-Day Fills24.0
Peer Average Days Supply663
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 35.0% more claims than the standard regional baseline profile for FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,402.83 across this reporting matrix range.

Provider Avg Cost Per Claim

$126.03

State Avg Cost Per Claim

$46.15

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A muscarinic antagonist used as an antispasmodic, in some disorders of the gastrointestinal tract, and to reduce salivation with some anesthetics.

Therapeutic Applications

Glycopyrrolate solution is used to reduce excessive drooling caused by medical conditions (such as cerebral palsy). This medication works by decreasing the amount of saliva you make. Glycopyrrolate belongs to a class of drugs known as anticholinergics.

Nuedexta

Generic Formulation: Dextromethorphan Hbr/QuinidineSpecialty: Neurology
Provider Metrics Summary
Total Claims 13
30-Day Fills 13.0
Days Supply 390
FL State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills30.0
Peer Average Days Supply583
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 55.2% less volume than the regional standard for practitioners inside FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $20,936.13 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,610.47

State Avg Cost Per Claim

$945.61

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat a certain mental/mood disorder (pseudobulbar affect). This disorder may occur due to various conditions that affect the brain (such as stroke, amyotrophic lateral sclerosis-ALS, multiple sclerosis). This medication may help decrease sudden outbursts of uncontrollable/inappropriate laughing and/or crying. This medication is a combination of 2 ingredients: dextromethorphan and quinidine. Dextromethorphan works in the brain, though it is not known exactly how it helps treat pseudobulbar affect. Quinidine is added to this medication to increase the effect of dextromethorphan.

Pregabalin

Generic Formulation: PregabalinSpecialty: Neurology
Provider Metrics Summary
Total Claims 20
30-Day Fills 26.0
Days Supply 765
FL State Average Benchmarks
Peer Average Claims50.0
Peer Average 30-Day Fills63.9
Peer Average Days Supply1,862
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 60.0% less volume than the regional standard for practitioners inside FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $615.91 across this reporting matrix range.

Provider Avg Cost Per Claim

$30.80

State Avg Cost Per Claim

$42.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A gamma-aminobutyric acid (GABA) derivative that functions as a CALCIUM CHANNEL BLOCKER and is used as an ANTICONVULSANT as well as an ANTI-ANXIETY AGENT. It is also used as an ANALGESIC in the treatment of NEUROPATHIC PAIN and FIBROMYALGIA.

Therapeutic Applications

This medication is used to treat pain caused by nerve damage due to diabetes, shingles (herpes zoster) infection, or spinal cord injury. This medication is also used to treat pain in people with fibromyalgia. It is also used with other medications to treat certain types of seizures (focal seizures).

Privigen

Generic Formulation: Immun Glob G(Igg)/Pro/Iga 0-50Specialty: Neurology
Provider Metrics Summary
Total Claims 15
30-Day Fills 15.0
Days Supply 329
FL State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills24.0
Peer Average Days Supply607
Conservative Utilization

This provider writes prescriptions for this formulation 37.5% less frequently than the standard regional baseline metric for practitioners inside FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $212,322.90 across this reporting matrix range.

Provider Avg Cost Per Claim

$14,154.86

State Avg Cost Per Claim

$11,756.43

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to boost the body's natural defense system against infection in persons with a weakened immune system (primary immune deficiency). Immune globulin contains natural substances called antibodies (a type called IgG) that come from healthy human blood (plasma). These antibodies help protect your body against infections and help you to fight an infection if you get sick. Some immune globulin products may also be used to treat a certain nerve disorder (chronic inflammatory demyelinating polyneuropathy-CIDP).

Pyridostigmine Bromide

Generic Formulation: Pyridostigmine BromideSpecialty: Neurology
Provider Metrics Summary
Total Claims 14
30-Day Fills 39.0
Days Supply 1,170
FL State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills44.8
Peer Average Days Supply1,302
Conservative Utilization

This provider writes prescriptions for this formulation 44.0% less frequently than the standard regional baseline metric for practitioners inside FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,660.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$118.58

State Avg Cost Per Claim

$135.87

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.

Therapeutic Applications

Pyridostigmine is used to improve muscle strength in patients with a certain muscle disease (myasthenia gravis). It works by preventing the breakdown of a certain natural substance (acetylcholine) in your body. Acetylcholine is needed for normal muscle function.

Radicava Ors

Generic Formulation: EdaravoneSpecialty: Neurology
Provider Metrics Summary
Total Claims 30
30-Day Fills 30.0
Days Supply 840
FL State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills37.0
Peer Average Days Supply1,035
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $436,255.66 across this reporting matrix range.

Provider Avg Cost Per Claim

$14,541.86

State Avg Cost Per Claim

$14,357.39

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antipyrine derivative that functions as a free radical scavenger and neuroprotective agent. It is used in the treatment of AMYOTROPHIC LATERAL SCLEROSIS and STROKE.

Therapeutic Applications

Edaravone is used to treat a certain type of nerve disease called amyotrophic lateral sclerosis (ALS, also commonly called Lou Gehrig's disease). It helps to slow down the worsening of this disease. However, it is not a cure for ALS, and it does not reverse nerve damage or muscle weakness.

Relyvrio

Generic Formulation: Sod Phenylbutyrat/TaurursodiolSpecialty: Neurology
Provider Metrics Summary
Total Claims 82
30-Day Fills 83.8
Days Supply 2,358
FL State Average Benchmarks
Peer Average Claims--
Peer Average 30-Day Fills--
Peer Average Days Supply--

Provider Avg Cost Per Claim

$12,611.91

State Avg Cost Per Claim

--

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat a certain type of nerve disease called amyotrophic lateral sclerosis (ALS, also commonly called Lou Gehrig's disease). This medication contains 2 drugs: sodium phenylbutyrate and taurursodiol (also known as ursodoxicoltaurine). It helps slow down loss of physical function due to this disease. However, it is not a cure for ALS, and it does not reverse nerve damage or muscle weakness.

Riluzole

Generic Formulation: RiluzoleSpecialty: Neurology
Provider Metrics Summary
Total Claims 53
30-Day Fills 92.0
Days Supply 2,735
FL State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills44.6
Peer Average Days Supply1,328
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 82.8% higher than the standard regional baseline profile for FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $10,534.57 across this reporting matrix range.

Provider Avg Cost Per Claim

$198.77

State Avg Cost Per Claim

$186.82

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Therapeutic Applications

This medication is used to treat a certain type of nerve disease called amyotrophic lateral sclerosis (ALS, also commonly called Lou Gehrig's disease). Riluzole helps to slow down the worsening of this disease and prolong survival.

Tizanidine Hcl

Generic Formulation: Tizanidine HclSpecialty: Neurology
Provider Metrics Summary
Total Claims 15
30-Day Fills 17.0
Days Supply 510
FL State Average Benchmarks
Peer Average Claims56.0
Peer Average 30-Day Fills77.2
Peer Average Days Supply2,111
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 73.2% less volume than the regional standard for practitioners inside FL. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $161.32 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.75

State Avg Cost Per Claim

$15.09

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat muscle spasms caused by certain conditions (such as multiple sclerosis, spinal cord injury). It works by helping to relax the muscles.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like NATHAN CARBERRY MD provides transparency into local medical care patterns within Miami, FL.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Neuromuscular Medicine** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.